Digital healthcare scale-up Vitaccess has been honored with a Queen’s Award for Enterprise in the Innovation category.

Now in its 55th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the UK, recognizing the success of exciting and innovative businesses that are leading the way with pioneering products or services.

Founded in Oxford in 2017, Vitaccess has rapidly grown to a team of 48 employees and gained global recognition as a full-service digital healthcare research provider and strategic consultancy.
The company’s innovation is a powerful digital real-world evidence platform, Vitaccess Real™, that connects biopharmaceutical companies and research partners in real time to patients in real life, across the world.

The cloud-based platform utilizes cutting-edge technology, data analytics, visualization dashboards, and ISO:17100-certified localization to deliver quality, nuanced data, enabling insights that make a real impact on patients’ lives.

Data is gathered via secure, tailor-made study apps, which are co-created with patients, patient advocates and medical professionals, with governance from ethics committees. Study apps are free to download and by participating, patients play a leading role in providing the information that helps researchers to better understand their condition and improve treatment.

Working with patients and patient advocacy groups around the world, Vitaccess is currently running international studies in oncology, rare diseases and chronic illnesses.

Dr Mark Larkin, Vitaccess Founder and CEO, commented

“From our Oxford roots, we now conduct global digital real-world evidence research with major biopharma companies. It is a huge honor after only four years to receive this most prestigious of awards, testament to the dedication and talents of our amazing team.”

Applications for Queen’s Awards for Enterprise 2022 open on 1st May 2021. For more information, visit

As celebrations couldn’t happen at Buckingham Palace, the Vitaccess team received the award from the hands of Sir Tom Shebbeare, KCVO, DL in Oxford on the 5th August 2021. 

Skip to content